ABVC BioPharma's market cap is currently $57.11M. The company's EPS TTM is $0.016; its P/E ratio is -10.13; ABVC BioPharma is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
